|
|
|
Multi-million dollar TB facility opens in Cape Town
SAPA 2001-02-09
The Global Alliance (GA) for TB Drug Development, which is carrying out research into the development of a more effective yet affordable cure for tuberculosis, officially opened its office in Cape Town on Monday.
The Global Alliance (GA) for TB Drug Development, which is carrying out research into the development of a more effective yet affordable cure for
tuberculosis, officially opened its office in Cape Town on Monday.
The GA was set up in October last year as a partnership between international governments, non-governmental
organisations, academia, foundations and industry. It has established three offices: one in New York, which deals with
administration; one in Brussels, responsible for advocacy and fund-raising; and one in Cape Town, housed on the
premises of the Medical Research Council (MRC) in Parow. The GA is seeking a TB treatment that is shorter than existing ones,
effective against drug-resistant strains, and accessible to the people who need it most.
Global funding for this public-private partnership is expected to exceed US150-million, it said in a statement on Friday.
The Cape Town office - the city has one of the highest incidences of the disease in the world - will co-ordinate the activities of a coalition
of stakeholders in countries worst affected by the disease.
The GA said two key components of its drug-development process were large-scale clinical trials and a rapid transfer of
new technology to populations, which stood to benefit most. It hoped, through the development of cost-effective new
drugs, to:
- Reduce the duration of TB treatment
- Improve the treatment of latent TB infection
- Be effective against multi-drug resistant TB.
The World Health Organisation (WHO) reported last year that a small but alarming percentage of people worldwide had
a form of TB that was resistant to the usual treatments and needed to be fought with stronger,
more expensive drugs to prevent a health crisis. WHO estimates that if more countries do not correctly treat the disease,
more than one billion people will be newly infected - and 35-million will die - in the next two decades.
About four percent of patients being treated have the multi-drug resistant form of the
disease.
(Source: SAPA, 05/02/01)
|